Heim000538 • SHE
add
Yunnan Baiyao Group Co Ltd
Við síðustu lokun
56,55 ¥
Dagbil
56,65 ¥ - 57,60 ¥
Árabil
49,00 ¥ - 67,10 ¥
Markaðsvirði
102,18 ma. CNY
Meðalmagn
9,03 m.
V/H-hlutf.
21,52
A/V-hlutfall
4,19%
Aðalkauphöll
SHE
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 10,84 ma. | 0,62% |
Rekstrarkostnaður | 1,42 ma. | -11,39% |
Nettótekjur | 1,93 ma. | 13,67% |
Hagnaðarhlutfall | — | — |
Hagnaður á hvern hlut | 1,06 | 12,44% |
EBITDA | 2,05 ma. | 21,95% |
Virkt skatthlutfall | 14,56% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 13,85 ma. | -19,26% |
Heildareignir | 54,25 ma. | -4,61% |
Heildarskuldir | 13,46 ma. | -11,87% |
Eigið fé alls | 40,79 ma. | — |
Útistandandi hlutabréf | 1,78 ma. | — |
Eiginfjárgengi | 2,47 | — |
Arðsemi eigna | 9,32% | — |
Ávöxtun eigin fjár | — | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 1,93 ma. | 13,67% |
Handbært fé frá rekstri | 713,60 m. | 35,39% |
Reiðufé frá fjárfestingum | -66,64 m. | -105,27% |
Reiðufé frá fjármögnun | -471,21 m. | -159,64% |
Breyting á handbæru fé | 176,78 m. | -93,15% |
Frjálst peningaflæði | -579,10 m. | -85,75% |
Um
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products.
The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species".
As of 2024 state, individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
Stofnsett
1902
Vefsvæði
Starfsfólk
9.277
